Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-103121
Filing Date
2026-03-12
Accepted
2026-03-12 08:05:33
Documents
97
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mbx-20251231.htm   iXBRL 10-K 3392157
2 EX-10.4 mbx-ex10_4.htm EX-10.4 199778
3 EX-23.1 mbx-ex23_1.htm EX-23.1 6012
4 EX-31.1 mbx-ex31_1.htm EX-31.1 17892
5 EX-31.2 mbx-ex31_2.htm EX-31.2 17906
6 EX-32.1 mbx-ex32_1.htm EX-32.1 15588
7 GRAPHIC img51445437_0.jpg GRAPHIC 107538
8 GRAPHIC img51445437_1.jpg GRAPHIC 63634
9 GRAPHIC img51445437_2.jpg GRAPHIC 557536
10 GRAPHIC img51445437_3.jpg GRAPHIC 429624
11 GRAPHIC img51445437_4.jpg GRAPHIC 66863
12 GRAPHIC img51445437_5.jpg GRAPHIC 63147
13 GRAPHIC img51445437_6.jpg GRAPHIC 48966
14 GRAPHIC img51445437_7.gif GRAPHIC 22942
15 GRAPHIC img51445437_8.jpg GRAPHIC 456763
  Complete submission text file 0001193125-26-103121.txt   16466203

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mbx-20251231.xsd EX-101.SCH 1449837
100 EXTRACTED XBRL INSTANCE DOCUMENT mbx-20251231_htm.xml XML 1943432
Mailing Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032
Business Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Filer) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-42272 | Film No.: 26745720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)